… reimbursing advanced EGFR-mutant lung adenocarcinoma patients receiving EGFR-TKI
as … , every EGFR-mutant patient in the present study had an equal chance to receive EGFR-…

… patients with lung adenocarcinoma who had not undergone prior radiotherapy or chemotherapy.
EGFR mutations … present study, EGFR mutations in lung adenocarcinoma patients were …

… patients according to their plasma EGFR mutation status. All 25 patients without detectable
plasma EGFR mutations … negative for plasma EGFR mutations after EGFR-TKI treatment and …

… for responses to EGFR TKIs, EGFR mutations also seem to … patients with untreated advanced
non-small cell lung cancer (… erlotinib, patients with EGFR mutations showed significantly …

… specific EGFR-mutant metastatic adenocarcinoma population … patients with EGFR-mutant
metastatic lung adenocarcinoma treated with a Food and Drug Administration–approved EGFR…

… Among tumors with EGFR mutation, there was no difference in OS (p = 0.140) … EGFR
mutation status was not a prognostic indicator after surgery in early-stage lung adenocarcinoma…

… prognostic for patients with lung adenocarcinoma. We aimed to explore the potential association
… EGFR mutation and the risk of BM in pulmonary adenocarcinoma patients. Data of 234 …

… second-site exon 21 EGFR mutation, T854A, in tumor cells from a patient with EGFR-mutant
lung adenocarcinoma and acquired resistance to EGFR tyrosine kinase inhibitors. The …

… cell lung cancer and the subsequent discovery of activating EGFR mutations have led to an
… of knowledge in the fields of EGFR biology, targeted therapeutics and lung cancer research. …

… To determine whether EGFR expression is commonly lost in EGFR mutant lung cancers
that transform to SCLC, we performed IHC analysis on seven resistant cases of EGFR mutant …